Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Imaging01:14

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans),  magnetic resonance imaging (MRI),  functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential patterning of dynamic brain states distinguish Parkinson's disease patients with mild cognitive impairments.

NeuroImage. Clinical·2025
Same author

Pre-trained convolutional neural networks identify Parkinson's disease from spectrogram images of voice samples.

Scientific reports·2025
Same author

Development and implementation of the frog-in-maze game to study upper limb movement in people with Parkinson's disease.

Scientific reports·2023
Same author

Analysis of Caregiver Burden Expressed in Social Media Discussions.

International journal of environmental research and public health·2023
Same author

The informed consent form navigator: a tool for producing readable and compliant consent documents.

Journal of clinical and translational science·2023
Same author

Feasibility of telemedicine research visits in people with Parkinson's disease residing in medically underserved areas.

Journal of clinical and translational science·2023

Related Experiment Video

Updated: May 28, 2026

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping
09:55

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

Alpha EEG guided TMS in schizophrenia.

Yi Jin1, Aaron S Kemp, Yueqin Huang

  • 1NeoSync, Inc., Newport Beach, California 92660, USA. jinyi@cox.net

Brain Stimulation
|October 25, 2011
PubMed
Summary

Alpha EEG guided Transcranial Magnetic Stimulation (αTMS) improved positive and general psychotic symptoms in schizophrenia patients. EEG normalization correlated with symptom improvement, suggesting a potential therapeutic mechanism.

More Related Videos

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping
09:55

Neuroimaging-Guided TMS–EEG for Real-Time Cortical Network Mapping

Published on: June 13, 2025

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
08:23

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy

Published on: November 13, 2016

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Technology

Background:

  • Alpha EEG guided Transcranial Magnetic Stimulation (αTMS) shows promise for negative symptoms of schizophrenia.
  • Investigating αTMS for other schizophrenia symptom domains and location specificity is crucial.

Purpose of the Study:

  • To evaluate αTMS efficacy across broader schizophrenia symptom domains.
  • To determine if αTMS therapeutic effects are location-specific.
  • To test the hypothesis that global alpha EEG normalization drives clinical improvement.

Main Methods:

  • Seventy-eight schizophrenia patients participated in a randomized, double-blind, sham-controlled trial.
  • Four groups received either frontal or parietal αTMS or sham treatment over 10 days.
  • Stimulus parameters were individualized based on alpha frequency and motor threshold.

Main Results:

  • Significant improvement in positive and general psychotic symptoms observed post-αTMS.
  • Frontal and parietal αTMS yielded comparable therapeutic effects.
  • Increased EEG Q factor (normalization) strongly correlated with symptom improvement across all domains.

Conclusions:

  • Alpha EEG normalization via αTMS may be a key mechanism for clinical improvement in schizophrenia.
  • Results are preliminary due to potential unblinding from sham control; further replication is needed.